Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Jefferies Financial
JEF
5
Amazon
AMZN
US Stock MarketDetailed Quotes
BDRX Biodexa Pharmaceuticals
- 1.490
- -0.020-1.32%
Close Apr 29 16:00 ET
3.82MMarket Cap-0.11P/E (TTM)
1.510High1.420Low51.89KVolume1.510Open1.510Pre Close76.01KTurnover2.25%Turnover RatioLossP/E (Static)2.56MShares73.99852wk High0.34P/B3.44MFloat Cap1.14052wk Low--Dividend TTM2.31MShs Float14680000.000Historical High--Div YieldTTM5.96%Amplitude1.140Historical Low1.464Avg Price1Lot Size
About Biodexa Pharmaceuticals Company
Biodexa Pharmaceuticals Plc is a drug delivery technology company. It is focused on the research and development of medicines for rare cancers, via both in-house programs as well as partnered programs. The firm's proprietary platform drug delivery technologies are Q-Sphera platform is a disruptive polymer microsphere technology, which is used for sustained release at the microscale to prolong and control the release of therapeutics over an extended period of time from weeks to months; Midasolve platform is an innovative nano saccharide technology, which is used to dissolve drugs at the nanoscale so that they can be administered in liquid form directly and locally into tumors; Midacore platform is an edge gold nanoparticle technology, which is used for targeting sites of disease at the nanoscale. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom.
Company Profile
SymbolBDRX
Company NameBiodexa Pharmaceuticals
Listing DateDec 7, 2015
Founded2000
CEOMr. Stephen Anthony Stamp
MarketNASDAQ
Employees13
Securities TypeDR
ADS Ratio1.0 : 10000.0
Fiscal Year Ends12-31
Address1 Caspian Point,Caspian Way
CityCardiff
ProvinceCardiff
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeCF10 4DQ
Phone44-1235-888-300
Websitehttp://www.biodexapharma.com
Company Executives
- Name
- Position
- Salary
- Stephen Anthony Stamp
- Executive Director,Chief Executive Officer and Chief Financial Officer
- --
- Dr. Stephen Barry Parker
- Non-Executive Director,Chairman
- --
- Dr. Sijmen de Vries
- Non-Executive Director
- --
- Dr. Simon Turton
- Non-Executive Director,Senior Independent Director
- --
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now